Home › Multipel myeloom › Californië › Sacramento
Multipel myeloom klinische studies in Sacramento, CA
8 studies voor Multipel myeloom zoeken deelnemers op locaties in en rond Sacramento (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
RekruterenFase 3
- Research Site, Sacramento
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruterenFase 2
- Kaiser Permanente - Sacramento Medical Center, Sacramento
- Sutter Sacramento, Sacramento
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RekruterenObservatieonderzoek
- University of California Davis Comprehensive Cancer Center, Sacramento
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RekruterenFase 3
- University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
- University of California, Sacramento
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RekruterenFase 3
- Mercy Cancer Center - Sacramento, Sacramento
- Woodland Memorial Hospital, Woodland · 16 mijl verwijderd
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RekruterenFase 1
- UC Davis Comprehensive Cancer Center, Sacramento
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RekruterenFase 3
- Mercy Cancer Center - Sacramento, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
- Woodland Memorial Hospital, Woodland · 16 mijl verwijderd
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
RekruterenFase 3
- University of California-Davis Cancer Center, Sacramento
Multipel myeloom studies in andere steden
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Andere studies in Sacramento
- Niet-kleincellige longkanker29 studies
- Longkanker22 studies
- Borstkanker20 studies
- Prostaatkanker19 studies
- Metastatische kanker16 studies
- Acute myeloïde leukemie12 studies
- Hartfalen12 studies
- Aldermeesklierkanker12 studies
- Dikkedarmkanker11 studies
- Kanker (alle vormen)11 studies
- Blasenkanker10 studies
- Colorectale kanker10 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.